ceftazidime

chemical compound

Uses your system voice; voice and rate in settings.

Q808845Snapshot

≈ 3 min read

Names in other languages

  • Englishceftazidime
  • Françaisceftazidime
  • Portuguêsceftazidima
  • DeutschCeftazidim
  • Polskiceftazydym
  • فارسیسفتازیدیم
  • 简体中文头孢他啶
  • 繁體中文頭孢他啶
  • 中文頭孢他啶

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ceftazidime, sold under the brand name Fortaz among others, is a third-generation cephalosporin antibiotic useful for the treatment of a number of bacterial infections. Specifically it is used for joint infections, meningitis, pneumonia, sepsis, urinary tract infections, malignant otitis externa, Pseudomonas aeruginosa infection, and vibrio infection.

It is given by injection into a vein, muscle, or eye. Common side effects include nausea, allergic reactions, and pain at the site of injection. Other side effects may include Clostridioides difficile diarrhea.

It is not recommended in people who have had previous anaphylaxis to a penicillin. Its use is relatively safe during pregnancy and breastfeeding. It is in the third-generation cephalosporin family of medications and works by interfering with the bacteria's cell wall.

Ceftazidime was patented in 1978 and came into commercial use in 1984. It is on the World Health Organization's List of Essential Medicines. Ceftazidime is available as a generic medication.

Medical uses

Ceftazidime is used to treat lower respiratory tract, skin, urinary tract, blood-stream, joint, and abdominal infections, and meningitis. Ceftazidime is the first-line treatment for the tropical infection, melioidosis, an important cause of sepsis in Asia and Australia.

Labeled indications include the treatment of patients with: Pseudomonas aeruginosa infections other Gram-negative, aerobic infections neutropenic fever As a class, cephalosporins have activity against Gram-positive and Gram-negative bacteria. The balance of activity tips toward Gram-positive organisms for earlier generations; later generations of cephalosporins have more Gram-negative coverage.

Ceftazidime is one of the few in this class with activity against Pseudomonas aeruginosa. However, ceftazidime is less effective for S. aureus than first and second generation cephalosporins. Also, cephalosporins until fifth generation are not active against methicillin-resistant Staphylococcus aureus.

Mechanism of action

Third-generation cephalosporins differ from earlier generations in the presence of a C=N-OCH 3 group in their chemical structure (cefuroxime & cefuzonam also bear this functional group but are only listed as class II). This group provides improved stability against certain beta-lactamase enzymes produced by Gram-negative bacteria.

These bacterial enzymes rapidly destroy earlier-generation cephalosporins by breaking open the drug's beta-lactam chemical ring, leading to antibiotic resistance. Though initially active against these bacteria, with widespread use of third-generation cephalosporins, some Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs) are even able to inactivate the third-generation cephalosporins.

Infections caused by ESBL-producing Gram-negative bacteria are of particular concern in hospitals and other healthcare facilities.

Chemistry

In addition to the syn-configuration of the imino side chain, compared to other third-generation cephalosporins, the more complex moiety (containing two methyl and a carboxylic acid group) confers extra stability to beta-lactamase enzymes produced by many Gram-negative bacteria. The extra stability to β-lactamases increases the activity of ceftazidime against otherwise resistant Gram-negative organisms including Pseudomonas aeruginosa.

The charged pyridinium moiety increases water-solubility. Ceftazidime shares the same variable R-group side chain with aztreonam, a monobactam antibiotic; the two drugs share a similar spectrum of activity, including activity against Pseudomonas aeruginosa.

See also

Ceftazidime/avibactam

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338929532 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

9 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.